Lifeboat Foundation

An international piece of research, led by the Instituto de Astrofísica de Canarias (IAC) has found clues to the nature of some of the brightest and hottest stars in our universe, called blue supergiants. Although these stars are commonly observed, their origin has been an old puzzle that has been debated for several decades.

Researchers at the University of Waterloo’s Institute for Quantum Computing (IQC) have brought together two Nobel prize-winning research concepts to advance the field of quantum communication.

A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in The New England Journal of Medicine, researchers from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, shared the results for the first three patient cases from a phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM). The trial, known as INCIPIENT, is designed to evaluate the safety of CARv3-TEAM-E T cells in patients with recurrent GBM. Just days after a single treatment, patients experienced dramatic reductions in their tumors, with one patient achieving near-complete tumor regression. In time, the researchers observed tumor progression in these patients, but given the strategy’s promising preliminary results, the team will pursue strategies to extend the durability of response.

“This is a story of bench-to-bedside therapy, with a novel cell therapy designed in the laboratories of Massachusetts General Hospital and translated for patient use within five years, to meet an urgent need,” said Bryan Choi, MD, PhD, neurosurgeon and associate director of the Center for Brain Tumor Immunology and Immunotherapy, Cellular Immunotherapy Program, Mass General Cancer Center and Department of Neurosurgery. “The CAR-T platform has revolutionized how we think about treating patients with cancer, but solid tumors like glioblastoma have remained challenging to treat because not all cancer cells are exactly alike and cells within the tumor vary. Our approach combines two forms of therapy, allowing us to treat glioblastoma in a broader, potentially more effective way.”

Scientists modeled human-like communication skills and the transfer of knowledge between AIs — so they can teach each other to perform tasks without a huge amount of training data.

Valter Longo, who wants to live to a healthy 120 or 130, sees the key to longevity in diet — legumes and fish — and faux fasting.

Tests aim to see if AI models can determine when you’re speaking to your phone without needing a trigger phrase.

The company has faced two main issues related to communications and the spacecraft rotation rate — and it’s largely solved both those problems.

So what happens if you combine reading glasses with sunglasses and put a chip in that so discretely that nobody can even tell?

That’s what Deep Optics has done with its latest 32°N-branded Muir sunglasses that I’ve been testing for the last few weeks. A swipe on the frame sends an electrical signal to the two liquid crystal lenses to change the state of millions of tiny pixels so that close objects come into focus.

As such, these 32 Degrees North specs eliminate the need to carry (and lose) both reading glasses and sunglasses — at least, that’s the promise made in exchange for $849 of your hard-earned money.

AI technology developed by Johns Hopkins University to detect COVID-19 in lung ultrasound images, revolutionizing medical diagnostics.